The effectiveness of dual antiplatelet treatment in acute ischemic stroke patients with intracranial arterial stenosis: A subgroup analysis of CLAIR study

International Journal of Stroke

Volumn 8, Issue 8, 2013, Pages 663-668

  Wang, Xin ^a,b   Lin, Wen Hua ^b   Zhao, Yu Dong ^c   Chen, Xiang Yan ^d   Leung, Thomas W ^b   Chen, Christopher ^f   Fu, Jianhui ^b,d   Markus, Hugh ^e   Hao, Qing ^b,f   Wong, Ka Sing ^b  

^a QINGDAO MUNICIPAL HOSPITAL   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c Singapore Clinical Research Institute ^*  (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e FUDAN UNIVERSITY   (China)

^f ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Dual antiplatelet treatment; Microembolic signal; Purely intracranial stenosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; ARTERY OCCLUSION; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; HUMAN; INTRACRANIAL ARTERIAL STENOSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OPEN STUDY; PRIORITY JOURNAL; RISK REDUCTION; TRANSCRANIAL DOPPLER; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; ULTRASOUND;

DUAL ANTIPLATELET TREATMENT; MICROEMBOLIC SIGNAL; PURELY INTRACRANIAL STENOSIS;

ASPIRIN; CEREBROVASCULAR DISORDERS; CONSTRICTION, PATHOLOGIC; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; STROKE; TICLOPIDINE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84888094237     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2012.00828.x     Document Type: Article

References (18)

1. Feldmann E, Daneault N, Kwan E etal. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 1990; 40:1541-1545.
2. Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996; 2s:1974-1980.
3. Wong LK. Global burden of intracranial atherosclerosis. Int J Stroke 2006; 1:158-159.
4. Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995; 26:14-20.
5. Kasner SE, Chimowitz MI, Lynn MJ etal. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006; 113:555-563.
6. Ovbiagele B, Cruz-Flores S, Lynn MJ, Chimowitz MI. Early stroke risk after transient ischemic attack among individuals with symptomatic intracranial artery stenosis. Arch Neurol 2008; 65:733-737.
7. Kasner SE, Lynn MJ, Chimowitz MI etal. Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology 2006; 67:1275-1278.
8. Wong KS. Is the measurement of cerebral microembolic signals a good surrogate marker for evaluating the efficacy of antiplatelet agents in the prevention of stroke? Eur Neurol 2005; 53:132-139.
9. Markus HS, Droste DW, Kaps M etal. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005; 111:2233-2240.
10. Wong KS, Chen C, Fu J etal. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol 2010; 9:489-497.
11. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324:71-86.
12. Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006; 367:1665-1673.
13. Meyer DM, Albright KC, Allison TA, Grotta JC. LOAD: a pilot study of the safety of loading of aspirin and clopidogrel in acute ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis 2008; 17:26-29.
14. Rahme RJ, Aoun SG, Batjer HH, Bendok BR. SAMMPRIS: end of intracranial stenting for atherosclerosis or back to the drawing board? Neurosurgery 2011; 69:N16-18.
15. Diener HC, Bogousslavsky J, Brass LM etal. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004; 364:331-337.
16. Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol 2007; 6:961-969.
17. Bhatt DL, Fox KA, Hacke W etal. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006; 354:1706-1717.
18. Man BL, Fu YP, Chan YY etal. Use of magnetic resonance angiography to predict long-term outcomes of ischemic stroke patients with concurrent stenoses in Hong Kong. Cerebrovasc Dis 2009; 28:112-118.